DGX vs NRC
DGX: A leading national provider of diagnostic testing and medical insights, delivering clinical laboratory services through an extensive network of patient centers and hospitals. NRC: NRC Health offers an AI-powered healthcare experience management platform designed to help organizations improve patient and employee engagement through deep human insights.
Side-by-side fundamentals
| Metric | DGX | NRC | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $233.01 | $19.51 | |
| Market cap as of 2026-08-03 | $25.7B | $440M | |
| P/E as of 2026-08-03 | 24.67 | 47.47 | DGX lower |
| PEG as of 2026-08-03 | 2.61 | n/a | |
| Net margin as of 2026-08-03 | +9.2% | +6.5% | DGX higher |
| Gross margin as of 2026-08-03 | +33.2% | +61.8% | NRC higher |
| Operating margin as of 2026-08-03 | +14.1% | +14.1% | NRC higher |
| ROE as of 2026-08-03 | +14.5% | +57.3% | NRC higher |
| ROA as of 2026-08-03 | +6.4% | +6.6% | NRC higher |
| Debt / equity as of 2026-08-03 | 0.75 | 5.78 | DGX lower |
| Revenue growth (YoY) as of 2026-08-03 | +9.9% | -1.9% | DGX higher |
| Revenue CAGR (3y) SEC XBRL | +3.7% | -3.2% | DGX higher |
| Dividend yield as of 2026-08-03 | +1.5% | +3.3% | NRC higher |
| Dividend streak (yrs) SEC XBRL | 5 | 2 | DGX higher |
| Beta as of 2026-08-03 | 0.16 | 0.88 | |
| 1-year return as of 2026-07-31 close | +39.2% | +56.1% | NRC higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.